** Shares of Medibank Private MPL.AX rise as much as 3.9% to a record high of A$4.502, last up 2.8%
** UBS hikes price target for insurer to A$4.90 from A$4.30, rates stock "Buy"
** Brokerage sees scope for gross margins to expand further into FY26E, given that premium rate rises are set to continue outpacing inflation in near term
** Three of 10 analysts rate the stock "buy" and seven "hold"; median PT is A$4.46 – data compiled by LSEG
** Stock up 17.9% this year
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.